With CEO hire, this biotech boasts an all-women C-suite

Three months after publicly launching, Kojin Therapeutics has named a managing partner at the Dana-Farber Cancer Institute as its first CEO. With the addition of Luba Greenwood's, Kojin now boasts an executive team made up entirely of women — a rarity in the male-dominated field of life sciences. Johnson& Johnson (NYSE: JNJ) veteran Kay Ahn is the startup's chief scientific officer, Lynn Abel is vice president of biochemistry and founder Vasanthi Viswanathan has stayed on as head of discovery …
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news